Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis

Cardiovascular Psychiatry and Neurology

Volumn 2013, Issue , 2013, Pages

  Huffman, Jeff C ^a,b   Celano, Christopher M ^a,b   Beach, Scott R ^a,b   Motiwala, Shweta R ^a,b   Januzzi, James L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROHORMONE;

CARDIOVASCULAR DISEASE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; PATHOGENESIS; PATIENT IDENTIFICATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING;

EID: 84877306566     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2013/695925     Document Type: Review

References (172)

1. Mavrides N., Nemeroff C., Treatment of depression in cardiovascular disease. Depression and Anxiety 2013 10.1002/da.22051
2. Celano C. M., Huffman J. C., Depression and cardiac disease: a review. Cardiology in Review 2011 19 3 130 142 2-s2.0-79955125398 10.1097/CRD. 0b013e31820e8106
3. Carney R. M., Freedland K. E., Depression in patients with coronary heart disease. The American Journal of Medicine 2008 121 11, supplement 1 S20 S27 2-s2.0-54049155775 10.1016/j.amjmed.2008.08.006
4. Lespérance F., Frasure-Smith N., Juneau M., Théroux P., Depression and 1-year prognosis in unstable angina. Archives of Internal Medicine 2000 160 9 1354 1360 2-s2.0-0342804414 (Pubitemid 30252784)
5. Schleifer S. J., Macari-Hinson M. M., Coyle D. A., Slater W. R., Kahn M., Gorlin R., Zucker H. D., The nature and course of depression following myocardial infarction. Archives of Internal Medicine 1989 149 8 1785 1789 2-s2.0-0024364785 (Pubitemid 19200834)
6. Thombs B. D., de Jonge P., Coyne J. C., Whooley M. A., Frasure-Smith N., Mitchell A. J., Zuidersma M., Eze-Nliam C., Lima B. B., Smith C. G., Soderlund K., Ziegelstein R. C., Depression screening and patient outcomes in cardiovascular care: a systematic review. The Journal of the American Medical Association 2008 300 18 2161 2171 2-s2.0-56149099474 10.1001/jama.2008.667
7. Thombs B. D., Bass E. B., Ford D. E., Stewart K. J., Tsilidis K. K., Patel U., Fauerbach J. A., Bush D. E., Ziegelstein R. C., Prevalence of depression in survivors of acute myocardial infarction: review of the evidence. Journal of General Internal Medicine 2006 21 1 30 38 2-s2.0-33645115842 10.1111/j.1525-1497.2005.00269.x
8. Kessler R. C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K. R., Rush A. J., Walters E. E., Wang P. S., The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). The Journal of the American Medical Association 2003 289 23 3095 3105 2-s2.0-0037831023 10.1001/jama.289.23.3095 (Pubitemid 37432885)
9. Hedayati S. S., Bosworth H. B., Kuchibhatla M., Kimmel P. L., Szczech L. A., The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International 2006 69 9 1662 1668 2-s2.0-33646501494 10.1038/sj.ki.5000308
10. Snyderman D., Wynn D., Depression in cancer patients. Primary Care-Clinics in Office Practice 2009 36 4 703 719 2-s2.0-71549163767 10.1016/j.pop.2009.07.008
11. Magyar-Russell G., Thombs B. D., Cai J. X., Baveja T., Kuhl E. A., Singh P. P., Montenegro M. B. B., The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. Journal of Psychosomatic Research 2011 71 4 223 231 10.1016/j.jpsychores.2011.02.014
12. Rutledge T., Reis V. A., Linke S. E., Greenberg B. H., Mills P. J., Depression in heart failure. A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. Journal of the American College of Cardiology 2006 48 8 1527 1537 2-s2.0-33749531197 10.1016/j.jacc.2006.06.055 (Pubitemid 44528168)
13. McCabe P. J., Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. Journal of Cardiovascular Nursing 2010 25 1 40 51 2-s2.0-76649085861 10.1097/JCN.0b013e3181b7be36
14. Tully P. J., Baker R. A., Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. Journal of Geriatric Cardiology 2012 9 2 197 208 10.3724/SP.J.1263.2011. 12221
15. Glassman A. H., Bigger J. T., Gaffney M., Shapiro P. A., Swenson J. R., Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Archives of General Psychiatry 2006 63 3 283 288 2-s2.0-33644782795 10.1001/archpsyc.63.3.283 (Pubitemid 43345352)
16. Lespérance F., Frasure-Smith N., Koszycki D., Laliberté M. A., van Zyl L. T., Baker B., Swenson J. R., Ghatavi K., Abramson B. L., Dorian P., Guertin M. C., Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial. The Journal of the American Medical Association 2007 297 4 367 379 2-s2.0-33846499596 10.1001/jama.297.4.367 (Pubitemid 46155798)
17. Huffman J. C., Mastromauro C. A., Sowden G. L., Wittmann C., Rodman R., Januzzi J. L., A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes. Psychosomatics 2011 52 1 26 33 2-s2.0-79959521451
18. Hance M., Carney R. M., Freedland K. E., Skala J., Depression in patients with coronary heart disease: a 12-month follow-up. General Hospital Psychiatry 1996 18 1 61 65 2-s2.0-0030071649 10.1016/0163-8343(95)00100-X (Pubitemid 26073205)
19. Martens E. J., Smith O. R. F., Winter J., Denollet J., Pedersen S. S., Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction. Psychological Medicine 2008 38 2 257 264 2-s2.0-38549165668 10.1017/S0033291707001377 (Pubitemid 351156591)
20. Kaptein K. I., de Jonge P., van den Brink R. H. S., Korf J., Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis. Psychosomatic Medicine 2006 68 5 662 668 2-s2.0-33749013548 10.1097/01.psy.0000233237.79085.57 (Pubitemid 44454633)
21. Koenig H. G., Depression outcome in inpatients with congestive heart failure. Archives of Internal Medicine 2006 166 9 991 996 2-s2.0-33646412852
22. Suzuki T., Shiga T., Kuwahara K., Kobayashi S., Suzuki S., Nishimura K., Suzuki A., Ejima K., Manaka T., Shoda M., Ishigooka J., Kasanuki H., Hagiwara N., Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing and Clinical Electrophysiology 2010 33 12 1455 1461 2-s2.0-78650115474 10.1111/j.1540-8159. 2010.02887.x
23. Kroenke K., Spitzer R. L., Williams J. B. W., The patient health questionnaire-2: validity of a two-item depression screener. Medical Care 2003 41 11 1284 1292 2-s2.0-0642311548 10.1097/01.MLR.0000093487.78664.3C
24. Kroenke K., Spitzer R. L., Williams J. B. W., The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 2001 16 9 606 613 2-s2.0-0034853189 10.1046/j.1525-1497.2001.016009606.x (Pubitemid 32823891)
25. Shankman S. A., Nadelson J., McGowan S. K., Sovari A. A., Vidovich M. I., The predictive power of depression screening procedures for veterans with coronary artery disease. Journal of Vascular Health and Risk Management 2012 8 233 238 10.2147/VHRM.S29424
26. Caro M. A., Sowden G. L., Mastromauro C. A., Mahnks S., Beach S. R., Januzzi J. L., Huffman J. C., Risk factors for positive depression screens in hospitalized cardiac patients. Journal of Cardiology 2012 60 1 72 77 10.1016/j.jjcc.2012.01.016
27. Mallik S., Spertus J. A., Reid K. J., Krumholz H. M., Rumsfeld J. S., Weintraub W. S., Agarwal P., Santra M., Bidyasar S., Lichtman J. H., Wenger N. K., Vaccarino V., Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Archives of Internal Medicine 2006 166 8 876 883 2-s2.0-33646159976 10.1001/archinte.166.8.876
28. Strik J. J. M. H., Lousberg R., Cheriex E. C., Honig A., One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. Journal of Psychosomatic Research 2004 56 1 59 66 2-s2.0-1342308018 10.1016/S0022-3999(03)00380-5 (Pubitemid 38264333)
29. Shanmugasegaram S., Russell K. L., Kovacs A. H., Stewart D. E., Grace S. L., Gender and sex differences in prevalence of major depression in coronary artery disease patients: a meta-analysis. Maturitas 2012 73 4 305 311 10.1016/j.maturitas.2012.09.005
30. Busch A. M., Borrelli B., Leventhal A. M., The relationship between smoking and depression post-acute coronary syndrome. Current Cardiovascular Risk Reports 2012 5 6 510 518
31. Spijkerman T. A., van den Brink R. H. S., Jansen J. H. C., Crijns H. J. G. M., Ormel J., Who is at risk of post-MI depressive symptoms? Journal of Psychosomatic Research 2005 58 5 425 432 2-s2.0-22144490165 10.1016/j. jpsychores.2005.02.005 (Pubitemid 40982204)
32. Frazier L., Yu E., Sanner J., Liu F., Udtha M., Cron S., Coulter S., Bogaev R. C., Gender differences in self-reported symptoms of depression among patients with acute coronary syndrome. Nursing Research and Practice 2012 2012 5 109251 10.1155/2012/109251
33. Pena F. M., Modenesi Rde F., Piraciaba M. C., Marins R. M., Souza L. B., Barcelos A. F., Soares Jda S., Prevalence and variables predictive of depressive symptoms in patients hospitalized for heart failure. Cardiology Journal 2011 18 1 18 25
34. Sin M. K., Personal characteristics predictive of depressive symptoms in Hispanics with heart failure. Issues in Mental Health Nursing 2012 33 8 522 527 10.3109/01612840.2012.687438
35. Lossnitzer N., Herzog W., Stork S., Wild B., Muller-Tasch T., Lehmkuhl E., Zugck C., Regitz-Zagrosek V., Incidence rates and predictors of major and minor depression in patients with heart failure. International Journal of Cardiology 2012 10.1016/j.ijcard.2012.01.062
36. Dunkel A., Kendel F., Lehmkuhl E., Babitsch B., Oertelt-Prigione S., Hetzer R., Regitz-Zagrosek V., Predictors of preoperative depressive risk in patients undergoing coronary artery bypass graft surgery. Clinical Research in Cardiology 2009 98 10 643 650 2-s2.0-70349501592 10.1007/s00392-009-0050-0
37. McKenzie L. H., Simpson J., Stewart M., A systematic review of pre-operative predictors of post-operative depression and anxiety in individuals who have undergone coronary artery bypass graft surgery. Psychology, Health and Medicine 2010 15 1 74 93 2-s2.0-77949526436 10.1080/13548500903483486
38. Freedenberg V., Thomas S. A., Friedmann E., Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Failure Clinics 2011 7 1 59 68 2-s2.0-78649402711 10.1016/j.hfc.2010.08. 008
39. Doering L. V., Moser D. K., Riegel B., McKinley S., Davidson P., Baker H., Meischke H., Dracup K., Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease. International Journal of Cardiology 2010 145 2 188 192 10.1016/j.ijcard.2009.05.025
40. Denollet J., Strik J. J., Lousberg R., Honig A., Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression. Psychotherapy and Psychosomatics 2006 75 6 346 352 2-s2.0-33750042901 10.1159/000095440 (Pubitemid 44584032)
41. Frasure-Smith N., Lespérance F., Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Archives of General Psychiatry 2008 65 1 62 71 2-s2.0-38049166240 10.1001/archgenpsychiatry.2007.4
42. de Schutter A., Lavie C. J., Milani R. V., Relative importance of comorbid psychological symptoms in patients with depressive symptoms following phase II cardiac rehabilitation. Postgraduate Medicine 2011 123 6 72 78 10.3810/pgm.2011.11.2497
43. Bankier B., Januzzi J. L., Littman A. B., The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosomatic Medicine 2004 66 5 645 650 2-s2.0-4944242642 10.1097/01.psy. 0000138126.90551.62 (Pubitemid 39332348)
44. Martens E. J., de Jonge P., Na B., Cohen B. E., Lett H., Whooley M. A., Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Archives of General Psychiatry 2010 67 7 750 758 2-s2.0-77954545303 10.1001/ archgenpsychiatry.2010.74
45. Parker G., Hyett M., Hadzi-Pavlovic D., Brotchie H., Walsh W., GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome. Psychiatry Research 2011 188 3 383 389 2-s2.0-79960698393 10.1016/j.psychres.2011.05.018
46. Dao T. K., Chu D., Springer J., Gopaldas R. R., Menefee D. S., Anderson T., Hiatt E., Nguyen Q., Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery. Journal of Thoracic and Cardiovascular Surgery 2010 140 3 606 610 2-s2.0-77955980810 10.1016/j.jtcvs.2009.10.046
47. Ladwig K. H., Baumert J., Marten-Mittag B., Kolb C., Zrenner B., Schmitt C., Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Archives of General Psychiatry 2008 65 11 1324 1330 2-s2.0-55749113547 10.1001/archpsyc.65.11.1324
48. von Känel R., Baumert J., Kolb C., Cho E. Y. N., Ladwig K. H., Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. Journal of Affective Disorders 2011 131 1-3 344 352 2-s2.0-79955890148 10.1016/j.jad.2010.12.002
49. Sears S. F., Hauf J. D., Kirian K., Hazelton G., Conti J. B., Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circulation: Arrhythmia and Electrophysiology 2011 4 2 242 250 10.1161/CIRCEP.110.957670
50. Phillips A. C., Batty G. D., Gale C. R., Deary I. J., Osborn D., MacIntyre K., Carroll D., Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study. Psychosomatic Medicine 2009 71 4 395 403 2-s2.0-67049087792 10.1097/PSY.0b013e31819e6706
51. Roest A. M., Zuidersma M., de Jonge P., Myocardial infarction and generalised anxiety disorder: 10-year follow-up. The British Journal of Psychiatry 2012 200 4 324 329 10.1192/bjp.bp.111.103549
52. Kroenke K., Spitzer R. L., Williams J. B. W., Löwe B., An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009 50 6 613 621 2-s2.0-73349105254 10.1176/appi.psy.50.6.613
53. Spitzer R. L., Kroenke K., Williams J. B. W., Löwe B., A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 2006 166 10 1092 1097 2-s2.0-33646815612 10.1001/archinte.166. 10.1092 (Pubitemid 43765180)
54. Pizzi C., Manzoli L., Mancini S., Bedetti G., Fontana F., Costa G. M., Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010 212 1 292 298 2-s2.0-77956229379 10.1016/j.atherosclerosis.2010.04.038
55. Ford D. E., Mead L. A., Chang P. P., Cooper-Patrick L., Wang N. Y., Klag M. J., Depression is a risk factor for coronary artery disease in men: the precursors study. Archives of Internal Medicine 1998 158 13 1422 1426 2-s2.0-0032528015 10.1001/archinte.158.13.1422 (Pubitemid 28317757)
56. Wulsin L. R., Singal B. M., Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine 2003 65 2 201 210 2-s2.0-0037346611 10.1097/01.PSY.0000058371.50240.E3 (Pubitemid 36359331)
57. Carney R. M., Rich M. W., Freedland K. E., Saini J., TeVelde A., Simeone C., Clark K., Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosomatic Medicine 1988 50 6 627 633 2-s2.0-0024239004 (Pubitemid 19016813)
58. Kop W. J., Stein P. K., Tracy R. P., Barzilay J. I., Schulz R., Gottdiener J. S., Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosomatic Medicine 2010 72 7 626 635 2-s2.0-77957708684 10.1097/PSY.0b013e3181eadd2b
59. van der Kooy K., van Hout H., Marwijk H., Marten H., Stehouwer C., Beekman A., Depression and the risk for cardiovascular diseases: systematic review and meta analysis. International Journal of Geriatric Psychiatry 2007 22 7 613 626 2-s2.0-34250890185 10.1002/gps.1723 (Pubitemid 47180373)
60. van Melle J. P., de Jonge P., Spijkerman T. A., Tijssen J. G. P., Ormel J., van Veldhuisen D. J., van den Brink R. H. S., van den Berg M. P., Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosomatic Medicine 2004 66 6 814 822 2-s2.0-9244225620 10.1097/01.psy.0000146294.82810.9c (Pubitemid 39552863)
61. Frasure-Smith N., Lesperance F., Talajic M., Depression and 18-month prognosis after myocardial infarction. Circulation 1995 91 4 999 1005 2-s2.0-0028913077
62. Whang W., Kubzansky L. D., Kawachi I., Rexrode K. M., Kroenke C. H., Glynn R. J., Garan H., Albert C. M., Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the nurses' health study. Journal of the American College of Cardiology 2009 53 11 950 958 2-s2.0-61549142787 10.1016/j.jacc.2008.10.060
63. Frasure-Smith N., Lesperance F., Talajic M., Depression following myocardial infarction: impact on 6-month survival. The Journal of the American Medical Association 1993 270 15 1819 1825 2-s2.0-0027495766 10.1001/jama.270.15. 1819 (Pubitemid 23301435)
64. Barth J., Schumacher M., Herrmann-Lingen C., Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 2004 66 6 802 813 2-s2.0-9244240975 10.1097/01.psy. 0000146332.53619.b2 (Pubitemid 39552862)
65. Myers V., Gerber Y., Benyamini Y., Goldbourt U., Drory Y., Post-myocardial infarction depression: increased hospital admissions and reduced adoption of secondary prevention measures-a longitudinal study. Journal of Psychosomatic Research 2012 72 1 5 10 10.1016/j.jpsychores.2011.09.009
66. Ziegelstein R. C., Fauerbach J. A., Stevens S. S., Romanelli J., Richter D. P., Bush D. E., Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of Internal Medicine 2000 160 12 1818 1823 2-s2.0-0034717541 (Pubitemid 30418820)
67. Kurdyak P. A., Gnam W. H., Goering P., Chong A., Alter D. A., The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study. BMC Health Services Research 2008 8 article 200 2-s2.0-55149093628 10.1186/1472-6963-8-200
68. Reese R. L., Freedland K. E., Steinmeyer B. C., Rich M. W., Rackley J. W., Carney R. M., Depression and rehospitalization following acute myocardial infarction. Circulation: Cardiovascular Quality and Outcomes 2011 4 6 626 633 10.1161/CIRCOUTCOMES.111.961896
69. Leung Y. W., Flora D. B., Gravely S., Irvine J., Carney R. M., Grace S. L., The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosomatic Medicine 2012 74 8 786 801 10.1097/PSY.0b013e31826ddbed
70. Freedland K. E., Carney R. M., Rich M. W., Effect of depression on prognosis in heart failure. Heart Failure Clinics 2011 7 1 11 21 2-s2.0-78649405487 10.1016/j.hfc.2010.08.003
71. Lange H. W., Herrmann-Lingen C., Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. Journal of Psychosomatic Research 2007 63 5 509 513 2-s2.0-35549000175 10.1016/j.jpsychores.2007.07.010 (Pubitemid 350007666)
72. Frasure-Smith N., Lespérance F., Habra M., Talajic M., Khairy P., Dorian P., Roy D., Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009 120 2 134 140 2-s2.0-67651091958 10.1161/CIRCULATIONAHA.109.851675
73. Beresnevait M., Benetis R., Taylor G. J., Jurnien K., Kinduris Š., Barauskien V., Depression predicts perioperative outcomes following coronary artery bypass graft surgery. Scandinavian Cardiovascular Journal 2010 44 5 289 294 2-s2.0-78649307709 10.3109/14017431.2010.490593
74. Morone N. E., Weiner D. K., Belnap B. H., Karp J. F., Mazumdar S., Houck P. R., He F., Rollman B. L., The impact of pain and depression on recovery after coronary artery bypass grafting. Psychosomatic Medicine 2010 72 7 620 625 2-s2.0-77957722674 10.1097/PSY.0b013e3181e6df90
75. Burg M. M., Benedetto M. C., Rosenberg R., Soufer R., Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery. Psychosomatic Medicine 2003 65 1 111 118 2-s2.0-0037253130 10.1097/01.PSY.0000038940.33335.09 (Pubitemid 36143203)
76. Goyal T. M., Idler E. L., Krause T. J., Contrada R. J., Quality of life following cardiac surgery: impact of the severity and course of depressive symptoms. Psychosomatic Medicine 2005 67 5 759 765 2-s2.0-25844481960 10.1097/01.psy.0000174046.40566.80 (Pubitemid 41396023)
77. Wellenius G. A., Mukamal K. J., Kulshreshtha A., Asonganyi S., Mittleman M. A., Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts. Circulation 2008 117 18 2313 2319 2-s2.0-43249104482 10.1161/CIRCULATIONAHA.107.741058 (Pubitemid 351653541)
78. Burg M. M., Benedetto M. C., Soufer R., Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosomatic Medicine 2003 65 4 508 510 2-s2.0-0042344947 10.1097/01.PSY. 0000077509.39465.79 (Pubitemid 36900242)
79. Blumenthal J. A., Lett H. S., Babyak M. A., White W., Smith P. K., Mark D. B., Jones R., Mathew J. P., Newman M. F., Depression as a risk factor for mortality after coronary artery bypass surgery. The Lancet 2003 362 9384 604 609 2-s2.0-0041464854 10.1016/S0140-6736(03)14190-6 (Pubitemid 37013300)
80. van den Broek K. C., Tekle F. B., Habibovic M., Alings M., van der Voort P. H., Denollet J., Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. International Journal of Cardiology 2011 10.1016/j.ijcard.2011.08.071
81. de Jonge P., Honig A., van Melle J. P., Schene A. H., Kuyper A. M. G., Tulner D., Schins A., Ormel J., Ormel J., Schene A. H., Honig A., Crijns H. J. G. M., Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. The American Journal of Psychiatry 2007 164 9 1371 1378 2-s2.0-34648828268 10.1176/appi.ajp.2007.06091492 (Pubitemid 47461137)
82. Carney R. M., Blumenthal J. A., Freedland K. E., Youngblood M., Veith R. C., Burg M. M., Cornell C., Saab P. G., Kaufmann P. G., Czajkowski S. M., Jaffe A. S., Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosomatic Medicine 2004 66 4 466 474 2-s2.0-3242803517 10.1097/01.psy.0000133362.75075.a6 (Pubitemid 38971239)
83. Roest A. M., Martens E. J., Denollet J., de Jonge P., Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosomatic Medicine 2010 72 6 563 569 2-s2.0-77954758156 10.1097/PSY.0b013e3181dbff97
84. Howland R. H., Wilson M. G., Kornstein S. G., Clayton A. H., Trivedi M. H., Wohlreich M. M., Fava M., Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. Annals of Clinical Psychiatry 2008 20 4 209 218 2-s2.0-57049148576 10.1080/10401230802437639
85. Rush A. J., Wisniewski S. R., Warden D., Luther J. F., Davis L. L., Fava M., Nierenberg A. A., Trivedi M. H., Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of General Psychiatry 2008 65 8 870 880 2-s2.0-48949088845 10.1001/archpsyc.65.8.870
86. Celano C. M., Mastromauro C. A., Lenihan E. C., Januzzi J. L., Rollman B. L., Huffman J. C., Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. Psychosomatic Medicine 2012 74 1 93 99 10.1097/PSY.0b013e31823d38bc
87. Davidson K. W., Burg M. M., Kronish I. M., Shimbo D., Dettenborn L., Mehran R., Vorchheimer D., Clemow L., Schwartz J. E., Lespérance F., Rieckmann N., Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Archives of General Psychiatry 2010 67 5 480 488 2-s2.0-77951888965 10.1001/archgenpsychiatry.2010. 36
88. Doyle F., Conroy R., McGee H., Differential predictive value of depressive versus anxiety symptoms in the prediction of 8-year mortality after acute coronary syndrome. Psychosomatic Medicine 2012 74 7 711 716 10.1097/PSY.0b013e318268978e
89. Damen N. L., Pelle A. J., Boersma E., Serruys P. W., van Domburg R. T., Pedersen S. S., Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. European Journal of Preventive Cardiology 2013 20 1 127 134 10.1177/2047487312436452
90. Coyne J. C., de Voogd J. N., Are we witnessing the decline effect in the type D personality literature? What can be learned? Journal of Psychosomatic Research 2012 73 6 401 407 10.1016/j.jpsychores.2012.09.016
91. Moyer C. F., Sajuthi D., Tulli H., Williams J. K., Synthesis of IL-1 α and IL-1 β by arterial cells in atherosclerosis. The American Journal of Pathology 1991 138 4 951 960
92. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 10.1056/NEJM199901143400207 (Pubitemid 29054847)
93. Hasper D., Hummel M., Kleber F. X., Reindl I., Volk H. D., Systemic inflammation in patients with heart failure. European Heart Journal 1998 19 5 761 765 2-s2.0-0032080919 10.1053/euhj.1997.0858 (Pubitemid 28227160)
94. Kania G., Blyszczuk P., Eriksson U., Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends in Cardiovascular Medicine 2009 19 8 247 252 2-s2.0-77952501955 10.1016/j.tcm.2010.02.005
95. Heeschen C., Hamm C. W., Bruemmer J., Simoons M. L., Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. Journal of the American College of Cardiology 2000 35 6 1535 1542 2-s2.0-0034111390 10.1016/S0735-1097(00)00581-7 (Pubitemid 30307497)
96. Kell R., Haunstetter A., Dengler T. J., Zugck C., Kübler W., Haass M., Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. European Heart Journal 2002 23 1 70 78 2-s2.0-0036399988 10.1053/euhj.2001.2780 (Pubitemid 35215121)
97. Jimenez J. A., Mills P. J., Neuroimmune mechanisms of depression in heart failure. Methods in Molecular Biology 2012 934 165 182 10.1007/978-1-62703-071- 7-9
98. Kop W. J., Synowski S. J., Gottlieb S. S., Depression in heart failure: biobehavioral mechanisms. Heart Failure Clinics 2011 7 1 23 38 2-s2.0-78649432280 10.1016/j.hfc.2010.08.011
99. Howren M. B., Lamkin D. M., Suls J., Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 2009 71 2 171 186 2-s2.0-65649152524 10.1097/PSY.0b013e3181907c1b
100. Miller A. H., Maletic V., Raison C. L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009 65 9 732 741 2-s2.0-63449122724 10.1016/j.biopsych.2008.11.029
101. Kop W. J., Kuhl E. A., Barasch E., Jenny N. S., Gottlieb S. S., Gottdiener J. S., Association between depressive symptoms and fibrosis markers: the cardiovascular health study. Brain, Behavior, and Immunity 2010 24 2 229 235 2-s2.0-72649103765 10.1016/j.bbi.2009.09.017
102. Vaccarino V., Johnson B. D., Sheps D. S., Reis S. E., Kelsey S. F., Bittner V., Rutledge T., Shaw L. J., Sopko G., Bairey Merz C. N., Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia. The national heart, lung, and blood institute-sponsored WISE study. Journal of the American College of Cardiology 2007 50 21 2044 2050 2-s2.0-36048941976 10.1016/j.jacc.2007.07.069 (Pubitemid 350087570)
103. Katafuchi T., Kondo T., Take S., Yoshimura M., Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Annals of the New York Academy of Sciences 2006 1088 230 237 2-s2.0-34447626274 10.1196/annals.1366.020 (Pubitemid 47092041)
104. Katafuchi T., Kondo T., Take S., Yoshimura M., Enhanced expression of brain interferon- α and serotonin transporter in immunologically induced fatigue in rats. European Journal of Neuroscience 2005 22 11 2817 2826 2-s2.0-29144494853 10.1111/j.1460-9568.2005.04478.x (Pubitemid 41811279)
105. Wirleitner B., Rudzite V., Neurauter G., Murr C., Kalnins U., Erglis A., Trusinskis K., Fuchs D., Immune activation and degradation of tryptophan in coronary heart disease. European Journal of Clinical Investigation 2003 33 7 550 554 2-s2.0-0037789558 10.1046/j.1365-2362.2003.01186.x (Pubitemid 36783213)
106. Skop B. P., Brown T. M., Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996 37 1 12 16 2-s2.0-0030050198 (Pubitemid 26021814)
107. Miyata K., Shimokawa H., Higo T., Yamawaki T., Katsumata N., Kandabashi T., Tanaka E., Takamura Y., Yogo K., Egashira K., Takeshita A., Sarpogrelate, a selective 5-HT(2A) serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model. Journal of Cardiovascular Pharmacology 2000 35 2 294 301 2-s2.0-12944316599 10.1097/00005344-200002000-00018 (Pubitemid 30073823)
108. Verma S., Wang C. H., Li S. H., Dumont A. S., Fedak P. W. M., Badiwala M. V., Dhillon B., Weisel R. D., Li R. K., Mickle D. A. G., Stewart D. J., A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002 106 8 913 919 2-s2.0-0037143638 10.1161/01.CIR.0000029802.88087.5E (Pubitemid 34925323)
109. Fischer D., Rossa S., Landmesser U., Spiekermann S., Engberding N., Hornig B., Drexler H., Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. European Heart Journal 2005 26 1 65 69 2-s2.0-13544251682 10.1093/eurheartj/ehi001 (Pubitemid 40221125)
110. Katz S. D., Hryniewicz K., Hriljac I., Balidemaj K., Dimayuga C., Hudaihed A., Yasskiy A., Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005 111 3 310 314 2-s2.0-12844270491 10.1161/01.CIR.0000153349.77489.CF (Pubitemid 40165337)
111. Cooper D. C., Milic M. S., Tafur J. R., Mills P. J., Bardwell W. A., Ziegler M. G., Dimsdale J. E., Adverse impact of mood on flow-mediated dilation. Psychosomatic Medicine 2010 72 2 122 127 2-s2.0-77649149162 10.1097/PSY.0b013e3181cdbfc0
112. Tomfohr L. M., Murphy M. L. M., Miller G. E., Puterman E., Multiwave associations between depressive symptoms and endothelial function in adolescent and young adult females. Psychosomatic Medicine 2011 73 6 456 461 2-s2.0-79960366984 10.1097/PSY.0b013e3182228644
113. Pizzi C., Manzoli L., Mancini S., Costa G. M., Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. European Heart Journal 2008 29 9 1110 1117 2-s2.0-45349092182 10.1093/eurheartj/ehn137 (Pubitemid 351844893)
114. Sherwood A., Hinderliter A. L., Watkins L. L., Waugh R. A., Blumenthal J. A., Impaired endothelial function in coronary heart disease patients with depressive symptomatology. Journal of the American College of Cardiology 2005 46 4 656 659 2-s2.0-23644448579 10.1016/j.jacc.2005.05.041 (Pubitemid 41132693)
115. Pizzi C., Mancini S., Angeloni L., Fontana F., Manzoli L., Costa G. M., Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clinical Pharmacology and Therapeutics 2009 86 5 527 532 2-s2.0-70350241791 10.1038/clpt.2009.121
116. Vikenes K., Farstad M., Nordrehaug J. E., Serotonin is associated with coronary artery disease and cardiac events. Circulation 1999 100 5 483 489 2-s2.0-0033520025 (Pubitemid 29360156)
117. Serebruany V. L., Suckow R. F., Cooper T. B., O'Connor C. M., Malinin A. I., Krishnan K. R. R., van Zyl L. T., Lekht V., Glassman A. H., Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. The American Journal of Psychiatry 2005 162 6 1165 1170 2-s2.0-20044370662 10.1176/appi.ajp.162.6.1165 (Pubitemid 40770700)
118. Serebruany V. L., Gurbel P. A., O'Connor C. M., Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacological Research 2001 43 5 453 462 2-s2.0-0034954784 10.1006/phrs.2001.0817 (Pubitemid 32578861)
119. Schins A., Hamulyák K., Scharpé S., Lousberg R., van Melle J., Crijns H., Honig A., Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sciences 2004 76 6 637 650 2-s2.0-9644257096 10.1016/j.lfs.2004.04.060 (Pubitemid 39573394)
120. Arora R. C., Meltzer H. Y., Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sciences 1989 44 11 725 734 2-s2.0-0024477533 (Pubitemid 19065973)
121. Hrdina P. D., Bakish D., Ravindran A., Chudzik J., Cavazzoni P., Lapierre Y. D., Platelet serotonergic indices in major depression: up-regulation of 5-HT(2A) receptors unchanged by antidepressant treatment. Psychiatry Research 1997 66 2-3 73 85 2-s2.0-0031557158 10.1016/S0165-1781(96)03046-6 (Pubitemid 27085354)
122. Nemeroff C. B., Knight D. L., Franks J., Craighead W. E., Krishnan K. R. R., Further studies on platelet serotonin transporter binding in depression. The American Journal of Psychiatry 1994 151 11 1623 1625 2-s2.0-0028116390 (Pubitemid 24337593)
123. Kuijpers P. M. J. C., Hamulyak K., Strik J. J. M. H., Wellens H. J. J., Honig A., β -thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Research 2002 109 2 207 210 2-s2.0-0036211588 10.1016/S0165-1781(02)00017-3 (Pubitemid 34258500)
124. Serebruany V. L., Glassman A. H., Malinin A. I., Sane D. C., Finkel M. S., Krishnan R. R., Atar D., Lekht V., O'Connor C. M., Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagulation and Fibrinolysis 2003 14 6 563 567 2-s2.0-0042833060 10.1097/00001721-200309000- 00008 (Pubitemid 37083172)
125. Gehi A., Musselman D., Otte C., Royster E. B., Ali S., Whooley M. A., Depression and platelet activation in outpatients with stable coronary heart disease: findings from the heart and soul study. Psychiatry Research 2010 175 3 200 204 2-s2.0-73449148992 10.1016/j.psychres.2009.01.010
126. Anand I. S., Fisher L. D., Chiang Y. T., Latini R., Masson S., Maggioni A. P., Glazer R. D., Tognoni G., Cohn J. N., Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-HeFT). Circulation 2003 107 9 1278 1283 2-s2.0-0037432301 10.1161/01.CIR.0000054164.99881.00 (Pubitemid 36314411)
127. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T., Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. The New England Journal of Medicine 1984 311 13 819 823 2-s2.0-0021194420 (Pubitemid 14035089)
128. Gold P. W., Wong M. L., Goldstein D. S., Gold H. K., Ronsaville D. S., Esler M., Alesci S., Masood A., Licinio J., Geracioti T. D., Perini G., DeBellis M. D., Holmes C., Vgontzas A. N., Charney D. S., Chrousos G. P., McCann S. M., Kling M. A., Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proceedings of the National Academy of Sciences of the United States of America 2005 102 23 8303 8308 2-s2.0-20444427990 10.1073/pnas.0503069102 (Pubitemid 40800084)
129. Frenneaux M. P., Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 2004 90 11 1248 1255 2-s2.0-7244240672 10.1136/hrt.2003.026146 (Pubitemid 39433981)
130. La Rovere M. T., Pinna G. D., Hohnloser S. H., Marcus F. I., Mortara A., Nohara R., Bigger J. T., Camm A. J., Schwartz P. J., Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001 103 16 2072 2077 2-s2.0-0035942099 (Pubitemid 32373010)
131. Buccelletti F., Gilardi E., Scaini E., Galiuto L., Persiani R., Biondi A., Basile F., Gentiloni Silveri N., Heart rate variability and myocardial infarction: systematic literature review and metanalysis. European Review for Medical and Pharmacological Sciences 2009 13 4 299 307 2-s2.0-69249157372
132. Schwartz P. J., Vanoli E., Stramba-Badiale M., de Ferrari G. M., Billman G. E., Foreman R. D., Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988 78 4 I 969 979 2-s2.0-0023753487
133. Kemp A. H., Quintana D. S., Gray M. A., Felmingham K. L., Brown K., Gatt J. M., Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biological Psychiatry 2010 67 11 1067 1074 2-s2.0-77951976542 10.1016/j.biopsych.2009.12.012
134. Glassman A. H., Bigger J. T., Gaffney M., van Zyl L. T., Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Archives of General Psychiatry 2007 64 9 1025 1031 2-s2.0-34548401617 10.1001/archpsyc.64.9.1025 (Pubitemid 47360847)
135. Dao T. K., Youssef N. A., Gopaldas R. R., Chu D., Bakaeen F., Wear E., Menefee D., Autonomic cardiovascular dysregulation as a potential mechanism underlying depression and coronary artery bypass grafting surgery outcomes. Journal of Cardiothoracic Surgery 2010 5 1, article 36 2-s2.0-77952075648 10.1186/1749-8090-5-36
136. Hashimoto K., Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010 64 4 341 357 2-s2.0-77955078119 10.1111/j.1440-1819.2010. 02113.x
137. Castrén E., Rantamäki T., The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010 70 5 289 297 2-s2.0-77949746666 10.1002/dneu.20758
138. Molendijk M. L., Bus B. A., Spinhoven P., Penninx B. W., Kenis G., Prickaerts J., Voshaar R. C., Elzinga B. M., Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Molecular Psychiatry 2011 16 11 1088 1095 10.1038/mp.2010.98
139. Ohira K., Takeuchi R., Shoji H., Miyakawa T., Fluoxetine-iduced cortical adult neurogenesis. Neuropsychopharmacology 2013 10.1038/npp.2013.2
140. Kim H., Li Q., Hempstead B. L., Madri J. A., Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. The Journal of Biological Chemistry 2004 279 32 33538 33546 2-s2.0-4043109885 10.1074/jbc.M404115200 (Pubitemid 39063002)
141. Okada S., Yokoyama M., Toko H., Tateno K., Moriya J., Shimizu I., Nojima A., Ito T., Yoshida Y., Kobayashi Y., Katagiri H., Minamino T., Komuro I., Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 8 1902 1909 10.1161/ATVBAHA.112.248930
142. Hashimoto K., Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Progress in Neurobiology 2013 100 15 29 10.1016/j.pneurobio.2012.09.001
143. Sabino V., Cottone P., Parylak S. L., Steardo L., Zorrilla E. P., Sigma-1 receptor knockout mice display a depressive-like phenotype. Behavioural Brain Research 2009 198 2 472 476 2-s2.0-59649121472 10.1016/j.bbr.2008.11.036
144. Maurice T., Su T. P., The pharmacology of sigma-1 receptors. Pharmacology and Therapeutics 2009 124 2 195 206 2-s2.0-70349116879 10.1016/j.pharmthera. 2009.07.001
145. Ito K., Hirooka Y., Matsukawa R., Nakano M., Sunagawa K., Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovascular Research 2012 93 1 33 40 10.1093/cvr/cvr255
146. Kunugi H., Hori H., Adachi N., Numakawa T., Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry and Clinical Neurosciences 2010 64 5 447 459 2-s2.0-77957359431 10.1111/j.1440-1819.2010.02135.x
147. Bauer L. K., Caro M. A., Beach S. R., Mastromauro C. A., Lenihan E., Januzzi J. L., Huffman J. C., Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. The American Journal of Cardiology 2012 109 9 1266 1271 10.1016/j.amjcard.2011.12.017
148. Whooley M. A., de Jonge P., Vittinghoff E., Otte C., Moos R., Carney R. M., Ali S., Dowray S., Na B., Feldman M. D., Schiller N. B., Browner W. S., Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. The Journal of the American Medical Association 2008 300 20 2379 2388 2-s2.0-57049134256 10.1001/jama.2008.711
149. May H. T., Sheng X., Catinella A. P., Horne B. D., Carlquist J. F., Joy E., Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression. Journal of Psychosomatic Research 2010 69 2 169 174 2-s2.0-77954625343 10.1016/j.jpsychores.2010.01.026
150. Casey E., Hughes J. W., Waechter D., Josephson R., Rosneck J., Depression predicts failure to complete phase-II cardiac rehabilitation. Journal of Behavioral Medicine 2008 31 5 421 431 2-s2.0-52049125439 10.1007/s10865-008- 9168-1
151. McGrady A., McGinnis R., Badenhop D., Bentle M., Rajput M., Effects of depression and anxiety on adherence to cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 2009 29 6 358 364 2-s2.0-74349104771 10.1097/HCR.0b013e3181be7a8f
152. Huffman J. C., Smith F. A., Fricchione G. L., Januzzi J. L., Nadelman S., Pirl W. F., Depression and failure of cholesterol lowering after acute myocardial infarction. Primary Care Companion to the Journal of Clinical Psychiatry 2010 12 1 PCC.08m00766 2-s2.0-78650487712 10.4088/PCC.08m00766blu
153. Gehi A. K., Ali S., Na B., Whooley M. A., Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Archives of Internal Medicine 2007 167 16 1798 1803 2-s2.0-34548642425 10.1001/archinte.167.16.1798 (Pubitemid 47403069)
154. Wessel T. R., Arant C. B., Olson M. B., Johnson B. D., Reis S. E., Sharaf B. L., Shaw L. J., Handberg E., Sopko G., Kelsey S. F., Pepine C. J., Merz C. N. B., Relationship of physical fitness versus body mass index with coronary artery disease and cardiovascular events in women. The Journal of the American Medical Association 2004 292 10 1179 1187 2-s2.0-4444265592 10.1001/jama.292.10. 1179 (Pubitemid 39167408)
155. Huffman J. C., Smith F. A., Blais M. A., Beiser M. E., Januzzi J. L., Fricchione G. L., Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. The American Journal of Cardiology 2006 98 3 319 324 2-s2.0-33745947282 10.1016/j.amjcard.2006.02.033 (Pubitemid 44062435)
156. Ziegelstein R. C., Kim S. Y., Kao D., Fauerbach J. A., Thumbs B. D., McCann U., Colburn J., Bush D. E., Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosomatic Medicine 2005 67 3 393 397 2-s2.0-19544370736 10.1097/01.psy.0000160475.38930.8d (Pubitemid 40731564)
157. Lichtman J. H., Bigger J. T. Jr., Blumenthal J. A., Frasure-Smith N., Kaufmann P. G., Lespérance F., Mark D. B., Sheps D. S., Taylor C. B., Froelicher E. S., Depression and coronary heart disease: recommendations for screening, referral, and treatment-a science advisory from the American heart association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes research. Circulation 2008 118 17 1768 1775 2-s2.0-55449113061 10.1161/CIRCULATIONAHA.108.190769
158. Elderon L., Smolderen K. G., Na B., Whooley M. A., Accuracy and prognostic value of American heart association: recommended depression screening in patients with coronary heart disease: data from the heart and soul study. Circulation: Cardiovascular Quality and Outcomes 2011 4 5 533 540 10.1161/CIRCOUTCOMES.110.960302
159. Rollman B. L., Belnap B. H., Mazumdar S., Houck P. R., He F., Alvarez R. J., Schulberg H. C., Reynolds C. F. III, McNamara D. M., A positive 2-item patient health questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality. Journal of Cardiac Failure 2012 18 3 238 245 10.1016/j.cardfail.2011.11.002
160. Thombs B. D., Ziegelstein R. C., Whooley M. A., Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. Journal of General Internal Medicine 2008 23 12 2014 2017 2-s2.0-57249094303 10.1007/s11606-008- 0802-y
161. Sowden G., Mastromauro C. A., Januzzi J. L., Fricchione G. L., Huffman J. C., Detection of depression in cardiac inpatients: feasibility and results of systematic screening. The American Heart Journal 2010 159 5 780 787 2-s2.0-77951613714 10.1016/j.ahj.2010.02.029
162. Smolderen K. G., Buchanan D. M., Amin A. A., Gosch K., Nugent K., Riggs L., Seavey G., Spertus J. A., Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory. Circulation: Cardiovascular Quality and Outcomes 2011 4 3 283 292 2-s2.0-79959767400 10.1161/CIRCOUTCOMES.110.960013
163. Ziegelstein R. C., Thombs B. D., Coyne J. C., de Jonge P., Routine screening for depression in patients with coronary heart disease. Never mind. Journal of the American College of Cardiology 2009 54 10 886 890 2-s2.0-68949218472 10.1016/j.jacc.2009.01.082
164. Davidson K. W., Rieckmann N., Clemow L., Schwartz J. E., Shimbo D., Medina V., Albanese G., Kronish I., Hegel M., Burg M. M., Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine 2010 170 7 600 608 2-s2.0-77951002940 10.1001/archinternmed.2010.29
165. Huffman J. C., Mastromauro C. A., Sowden G., Fricchione G. L., Healy B. C., Januzzi J. L., Impact of a depression care management program for hospitalized cardiac patients. Circulation: Cardiovascular Quality and Outcomes 2011 4 2 198 205 10.1161/CIRCOUTCOMES.110.959379
166. Katon W. J., Lin E. H. B., Korff M. V., Ciechanowski P., Ludman E. J., Young B., Peterson D., Rutter C. M., McGregor M., McCulloch D., Collaborative care for patients with depression and chronic illnesses. The New England Journal of Medicine 2010 363 27 2611 2620 2-s2.0-78650858488 10.1056/NEJMoa1003955
167. Rollman B. L., Belnap B. H., LeMenager M. S., Mazumdar S., Houck P. R., Counihan P. J., Kapoor W. N., Schulberg H. C., Reynolds C. F., Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. The Journal of the American Medical Association 2009 302 19 2095 2103 2-s2.0-71849098875 10.1001/jama.2009.1670
168. Whooley M. A., To screen or not to screen? Depression in patients with cardiovascular disease. Journal of the American College of Cardiology 2009 54 10 891 893 2-s2.0-68949214664 10.1016/j.jacc.2009.05.034
169. Glassman A. H., O'Connor C. M., Califf R. M., Swedberg K., Schwartz P., Bigger J. T. Jr., Krishnan K. R. R., van Zyl L. T., Swenson J. R., Finkel M. S., Landau C., Shapiro P. A., Pepine C. J., Mardekian J., Harrison W. M., Sertraline treatment of major depression in patients with acute MI or unstable angina. The Journal of the American Medical Association 2002 288 6 701 709 2-s2.0-0037077490 (Pubitemid 34848222)
170. O'Connor C. M., Jiang W., Kuchibhatla M., Silva S. G., Cuffe M. S., Callwood D. D., Zakhary B., Stough W. G., Arias R. M., Rivelli S. K., Krishnan R., Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. Journal of the American College of Cardiology 2010 56 9 692 699 2-s2.0-77955862043 10.1016/j.jacc.2010.03.068
171. Berkman L. F., Blumenthal J., Burg M., Carney R. M., Catellier D., Cowan M. J., Czajkowski S. M., DeBusk R., Hosking J., Jaffe A., Kaufmann P. G., Mitchell P., Norman J., Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. The Journal of the American Medical Association 2003 289 23 3106 3116 2-s2.0-0038507402 10.1001/jama.289.23.3106 (Pubitemid 37432886)
172. Freedland K. E., Skala J. A., Carney R. M., Rubin E. H., Lustman P. J., Dávila-Román V. G., Steinmeyer B. C., Hogue C. W., Treatment of depression after coronary artery bypass surgery a randomized controlled trial. Archives of General Psychiatry 2009 66 4 387 396 2-s2.0-64849105453 10.1001/archgenpsychiatry.2009.7